Timeline, a Swiss Longevity Biotech, Secures Pivotal Financing Round with Support from Strategic Global Industry Leaders, including L’Oréal and Nestlé
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
"This strategic collaboration reflects the breakthrough multidimensional approach that we've always believed is necessary to make meaningful advancements for longevity and healthspan." said Patrick Aebischer, Co-Founder and Chairman of Timeline "I want to thank L'Oréal, Nestlé and our longstanding investors for their commitment to longevity solutions rooted in the highest level of science".
"Longevity is about living healthier for longer and L'Oréal has been working for a decade to understand and anticipate what this could mean for beauty," said Barbara Lavernos, Deputy Chief Executive Officer and in charge of Research, Innovation and Technology, L'Oréal. "Longevity is a new definition of beauty, at the intersection of different scientific disciplines, from decoding biological markers to analyzing external exposure. Our investment in Timeline is exciting for its potential to transpose key hallmarks of longevity onto skin health and beauty."
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
LAUSANNE, Switzerland -- Businesswire -- Timeline, a consumer health biotech company at the forefront of developing innovative solutions for healthy aging and longevity, today announces that it raised CHF 56M (USD 66M) in an oversubscribed Series D financing round. This marks a significant milestone for the company and includes strategic investments from two global industry leaders—L’Oréal and Nestlé.
The financing round was led by BOLD (Business Opportunities for L’Oréal Development), L‘Oréal Groupe’s strategic innovation venture capital fund, underscoring investors confidence in the company’s proprietary technology, Mitopure®, to help people live healthier for longer. Mitopure® is backed by over 15 years of research and is clinically proven to target a key cellular longevity pathway, by recycling and renewing the powerhouses inside cells, the mitochondria. Optimal mitochondrial function is essential for maintaining cellular energy which supports muscle strength, cognition, immune resilience, skin vitality and other important benefits, offering a comprehensive approach to promoting healthspan.
The support of these industry leaders and the funds raised will be used to build Timeline into a leading longevity consumer health brand by expanding the science, product categories, and markets across food, beauty and health sectors.
“This strategic collaboration reflects the breakthrough multidimensional approach that we've always believed is necessary to make meaningful advancements for longevity and healthspan.” said Patrick Aebischer, Co-Founder and Chairman of Timeline “I want to thank L’Oréal, Nestlé and our longstanding investors for their commitment to longevity solutions rooted in the highest level of science”.
“Longevity is about living healthier for longer and L’Oréal has been working for a decade to understand and anticipate what this could mean for beauty,” said Barbara Lavernos, Deputy Chief Executive Officer and in charge of Research, Innovation and Technology, L’Oréal. “Longevity is a new definition of beauty, at the intersection of different scientific disciplines, from decoding biological markers to analyzing external exposure. Our investment in Timeline is exciting for its potential to transpose key hallmarks of longevity onto skin health and beauty.”
“We have been an investor in Timeline since 2019 and continue to be very impressed with the team and stand behind the exponential potential that the Mitopure technology holds for nutrition to help people age better,” said Anna Mohl, CEO of Nestlé Health Science “We’re excited to have L’Oréal join as an investor and strategic partner to bring this technology to new heights and extend its applications.”
About Timeline
Timeline (parent company Amazentis) is a pioneering Swiss health science company committed to revolutionizing the longevity industry with its groundbreaking, clinically proven, proprietary ingredient Mitopure®. Offering a comprehensive approach to cellular health, Timeline incorporates the benefits of Mitopure inside its next generation nutritional supplements and topical skin health products. With more than a decade of expertise in aging science research, Timeline seeks to push the boundaries of human healthspan, contributing to a future where everyone can live longer, healthier lives. The company is backed by over 15 years of research by distinguished scientists, multiple clinical studies, over 50 patents and Nestlé Health Science has been an investor since 2019. More information on www.timelinenutrition.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240117576326/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Timeline
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 아이지, 반도체 플라즈마 응용 실습 장비 개발… 공급 본격화 - 뉴스와이어
- 원텍, 중국 SBT와 합작법인 설립 계약 체결 - 뉴스와이어
- 2024 코리아 메타버스 페스티벌, ‘메타버스 주간’ 운영 및 행사 연계 개최 - 뉴스와이어
- 한국디지털광고협회 ‘2024년 대한민국 디지털 광고 대상’ 개최 - 뉴스와이어
- 사랑의달팽이, 우리금융미래재단과 함께 청각장애인 101명에 소리 선물 - 뉴스와이어
- 일렉트로닉 월드 뮤직 듀오 애니멀다이버스, 두번째 정규 앨범 ‘Odyssey’ 발매 - 뉴스와이어
- 엔씨소프트, 국내 최초 LLM 성능 검증하는 ‘VARCO Judge LLM’ 출시 - 뉴스와이어
- 에쓰-오일토탈에너지스윤활유, 쿼츠 엔진오일 신규 광고 공개 - 뉴스와이어
- 국립나주병원, 직장인 정신건강 심포지엄 개최 - 뉴스와이어
- KOREA LIFE SCIENCE WEEK 2024 & KOREA LAB Autumn 2024 전시·컨퍼런스 개최 - 뉴스와이어